The novel therapy of this peptide represents a major breakthrough in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide198338.life3dblog.com/40454845/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment